Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-14-022064
Filing Date
2014-05-19
Accepted
2014-05-19 10:09:45
Documents
1
Period of Report
2014-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5837
  Complete submission text file 0001140361-14-022064.txt   7187
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 579 BELLEVUE AVE NEWPORT RI 02840
Business Address
DAWES KAREN A (Reporting) CIK: 0001261506 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 14853462